Expression of Genes Encoding Cell Motility Proteins during Progression of Head and Neck Squamous Cell Carcinoma
- Авторлар: Cheremisina O.V.1, Novikov V.A.1, Choinzonov E.L.1,2, Kakurina G.V.1, Kondakova I.V.1, Spirina L.V.1,2, Kolegova E.S.1, Shashova E.E.1
-
Мекемелер:
- Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences
- Siberian State Medical University
- Шығарылым: Том 166, № 2 (2018)
- Беттер: 250-252
- Бөлім: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/240935
- DOI: https://doi.org/10.1007/s10517-018-4325-1
- ID: 240935
Дәйексөз келтіру
Аннотация
The model of head and neck squamous cell carcinoma (HNSCC) was used to study the expression of genes encoding actin-binding proteins depending on the type of cell motility. The expression of SNAIL1 and CAPN2 mRNA in HNSCC tissue was higher than in specimens of dysplastic epithelium of the larynx and hypopharynx, which can be explained by activation of mesenchymal and amoeboid types of cell motility. In biopsy material of HNSCC patients with T1-2N0M0, expression of genes responsible for actin-binding proteins differed from that of patients with pretumor pathology of the larynx and hypopharynx: expression of FSCN was lower, while expressions of EZR and CAP1 were higher. The data attest that progression of HNSCC is associated with activation of both types of cell motility and with the changes in the expression of mRNA encoding cell motility proteins.
Авторлар туралы
O. Cheremisina
Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences
Email: kakurinagv@oncology.tomsk.ru
Ресей, Moscow
V. Novikov
Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences
Email: kakurinagv@oncology.tomsk.ru
Ресей, Moscow
E. Choinzonov
Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences; Siberian State Medical University
Email: kakurinagv@oncology.tomsk.ru
Ресей, Moscow; Tomsk
G. Kakurina
Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences
Хат алмасуға жауапты Автор.
Email: kakurinagv@oncology.tomsk.ru
Ресей, Moscow
I. Kondakova
Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences
Email: kakurinagv@oncology.tomsk.ru
Ресей, Moscow
L. Spirina
Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences; Siberian State Medical University
Email: kakurinagv@oncology.tomsk.ru
Ресей, Moscow; Tomsk
E. Kolegova
Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences
Email: kakurinagv@oncology.tomsk.ru
Ресей, Moscow
E. Shashova
Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences
Email: kakurinagv@oncology.tomsk.ru
Ресей, Moscow
Қосымша файлдар
